Market Overview

Quanterix to Present at the Canaccord Genuity 38th Annual Growth Conference

Share:

Quanterix
Corporation
(NASDAQ:QTRX), a company digitizing biomarker analysis
with the goal of advancing the science of precision health, today
announced that Kevin Hrusovsky, Chief Executive Officer, President and
Chairman of Quanterix, will present at the Canaccord
Genuity 38th Annual Growth Conference
, on Thursday, Aug. 9, 2018 at
10 a.m., EDT at the InterContinental Boston. Hrusovsky will also be
available for one-on-one meetings at the conference.

To access the live webcast of Quanterix' presentation, please visit the
News & Events page within the Investors section of the Quanterix website
at www.quanterix.com.
Replays of the webcast will be available for 90 days following each
conference.

About Quanterix

Quanterix is a company that is digitizing biomarker analysis with the
goal of advancing the science of precision health. The company's digital
health solution, Simoa, has the potential to change the way in which
healthcare is provided today by giving researchers the ability to
closely examine the continuum from health to disease through
ultrasensitive detection of biomarkers and to accelerate drug
development and approval. Quanterix' technology is designed to enable
much earlier disease detection, better prognoses and enhanced treatment
methods to improve the quality of life and longevity of the population
for generations to come. The technology is currently being used for
research applications in several therapeutic areas, including oncology,
neurology, cardiology, immunology and infectious disease. The company
was established in 2007 and is located in Lexington, Massachusetts. For
additional information, please visit https://www.quanterix.com.

Forward-Looking Statements

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Words
such as "may," "will," "expect," "plan," "anticipate," "estimate,"
"intend" and similar expressions (as well as other words or expressions
referencing future events, conditions or circumstances) are intended to
identify forward-looking statements. Forward-looking statements in this
news release include, but are not limited to Simoa's potential ability
to change the way in which healthcare is provided today, and are based
on Quanterix's expectations and assumptions as of the date of this press
release. Each of these forward-looking statements involves risks and
uncertainties. Factors that may cause Quanterix's actual results to
differ from those expressed or implied in the forward-looking statements
in this press release are discussed in Quanterix's filings with the U.S.
Securities and Exchange Commission, including the "Risk Factors"
sections contained therein. Except as required by law, Quanterix assumes
no obligation to update any forward-looking statements contained herein
to reflect any change in expectations, even as new information becomes
available.

View Comments and Join the Discussion!